Jingyuan Zhang Selected Research

kushen

3/2022	An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
10/2021	Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment.
1/2021	An Advanced Systems Pharmacology Strategy Reveals AKR1B1, MMP2, PTGER3 as Key Genes in the Competing Endogenous RNA Network of Compound Kushen Injection Treating Gastric Carcinoma by Integrated Bioinformatics and Experimental Verification.
1/2021	High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
1/2020	Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
1/2020	Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingyuan Zhang Research Topics

Disease

17	Neoplasms (Cancer) 05/2022 - 09/2006
8	Inflammation (Inflammations) 01/2022 - 12/2019
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
6	Infections 01/2020 - 05/2018
5	Lung Neoplasms (Lung Cancer) 02/2020 - 05/2017
4	Insulin Resistance 02/2022 - 11/2020
4	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2020
3	Leukopenia 03/2022 - 01/2020
3	Thrombocytopenia (Thrombopenia) 03/2022 - 01/2020
3	Non-alcoholic Fatty Liver Disease 02/2022 - 01/2020
3	Hepatitis B 01/2022 - 10/2020
3	Hypoxia (Hypoxemia) 01/2021 - 07/2010
2	Diabetes Complications 07/2022 - 09/2021
2	Body Weight (Weight, Body) 01/2022 - 12/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 08/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2020
2	Myocardial Infarction 01/2022 - 01/2021
2	Vomiting 10/2021 - 04/2020
2	Nausea 10/2021 - 04/2020
2	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 01/2020
2	COVID-19 06/2021 - 01/2021
2	Hearing Loss (Hearing Impairment) 01/2021 - 11/2013
2	Pulmonary Arterial Hypertension 01/2021 - 11/2020
2	Unstable Angina 01/2021 - 03/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 03/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 10/2019
1	Atherosclerosis 07/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022
1	Ovarian Cysts (Ovarian Cyst) 05/2022
1	Spontaneous Rupture 05/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2022
1	Diabetes Mellitus 02/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Genomic Instability 01/2022
1	Chagas Disease (American Trypanosomiasis) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Respiratory Hypersensitivity 11/2021
1	Asthma (Bronchial Asthma) 11/2021
1	African Swine Fever 11/2021
1	Viremia 11/2021
1	Vascular Remodeling 11/2021

Drug/Important Bio-Agent (IBA)

8	ArsenicIBA 02/2022 - 01/2020
7	CytokinesIBA 01/2022 - 12/2016
7	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2016
6	kushenIBA 03/2022 - 01/2020
6	Biological ProductsIBA 03/2022 - 01/2017
5	InflammasomesIBA 02/2022 - 03/2020
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2019
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2017
4	Pharmaceutical PreparationsIBA 03/2022 - 01/2017
3	Therapeutic UsesIBA 07/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2017
3	danhongIBA 01/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 10/2021 - 10/2016
2	MethyltransferasesIBA 02/2022 - 05/2017
2	Insulin (Novolin)FDA Link 02/2022 - 11/2020
2	yin zhi huangIBA 01/2022 - 10/2020
2	LipidsIBA 01/2022 - 02/2020
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2022 - 01/2021
2	InterleukinsIBA 11/2021 - 01/2020
2	Competitive Endogenous RNAIBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2021 - 01/2020
2	CollagenIBA 01/2021 - 03/2020
2	Peroxidase (Myeloperoxidase)IBA 12/2020 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2016
2	Histone Deacetylase InhibitorsIBA 01/2017 - 04/2016
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2013
1	RelaxinIBA 07/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2022
1	6-methyladenineIBA 02/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	Triglycerides (Triacylglycerol)IBA 02/2022
1	Ellagic AcidIBA 02/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022
1	16S Ribosomal RNAIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	chrysinIBA 01/2022
1	HomocysteineIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	MacrolidesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	histidine-rich proteinsIBA 01/2022
1	carrimycinIBA 01/2022
1	OvalbuminIBA 11/2021
1	Interleukin-22 (IL-22)IBA 11/2021
1	Viral DNAIBA 11/2021
1	VaccinesIBA 11/2021
1	SB 203580IBA 11/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2021

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 05/2022 - 01/2020
6	Injections 10/2021 - 01/2020
5	Therapeutics 01/2022 - 09/2006
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 03/2020
2	Treatment Delay 01/2021 - 07/2018